Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in India

Dimensions

Malaisamy, Muniyandi and Ramraj, Balaji and Vadamalai, Sathishkumar and Abdul Salam, Sahil and Devaleenal, Bella and Jaju, Jyoti and Chandrasekaran, Padmapriyadarsini (2025) Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in India. Comparing cost-effectiveness of short-course regimens for drug-resistant tuberculosis treatment in India, 41(1) (e48). pp. 1-12.

Text
202535.pdf - Published Version
Download (1MB)

Official URL: https://doi.org/10.1017/S0266462325100329

Abstract

Short-course regimens are currently explored to improve multidrug-resistant tuberculosis effects, reduce costs, as well as enhance patient adherence. Currently, we are determining the most cost-effective shorter regimen out of seven short-course regimens (6–9 months) to treat drug-resistant tuberculosis (DR-TB) compared to the current standard of care (SoC) 9- to 11-month regimen.

Affiliation:	ICMR-National Institute for Research in Tubercuosis
Item Type:	Article
URI:	http://eprints.nirt.res.in/id/eprint/2072

Actions (login required)

View Item